Search results
Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
Zacks via Yahoo News· 3 days agoThe FDA's CRL to Merck (MRK) and its partner Daiichi Sankyo for the patritumab deruxtecan BLA is...
The FDA's CRL to Merck (MRK) and its partner Daiichi Sankyo for the patritumab deruxtecan BLA is...